ROCKETSCRIPT
Live / Registered — Registered — Section 8 accepted (as of 05 Jun 2025)
What this means for you
Registered since 24 Dec 2019. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88018527
- Registration number
- 5941246
- Mark type
- Stylized text
- Filed
- 28 Jun 2018
- Published for opposition
- 08 Oct 2019
- Registered
- 24 Dec 2019
- Attorney of record
- Steven J. Hultquist
Goods and services
- Class 001 — Chemicals: biological enzymes for non-medical use; compositions for use in cDNA synthesis for research purposes; kits for use in cDNA synthesis for research purposes comprised of reagents, buffers, reverse transcriptase, oligomer; compositions for use in nucleic acid fluorescence staining for research purposes; kits for use in nucleic acid fluorescence staining for research purposes consisting of reagents, buffers, staining reagents; compositions for use in DNA sequence analysis for research purposes; kits for use in DNA sequence analysis for research purposes consisting of reagents, buffers, DNA polymerase; nucleic acid polymerase for research purposes; compositions for use in nucleic acid amplification for research purposes; kits for use in nucleic acid amplification for research purposes consisting of reagents, buffers, nucleic acid polymerase; chemical reagents for research purposes; compositions for use in polymerase chain reaction for research purposes; compositions for use in reverse transcription for research purposes
- Class 005 — Pharmaceuticals: biological enzymes for medical use; kits for use in cDNA synthesis for medical purposes comprised of reagents, buffers, reverse transcriptase, oligomer; compositions for use in nucleic acid fluorescence staining for medical purposes; kits for use in nucleic acid fluorescence staining for medical purposes consisting of reagents, buffers, staining reagents; compositions for use in DNA sequence analysis for medical purposes; kits for use in DNA sequence analysis for medical purposes consisting of reagents, buffers, DNA polymerase; nucleic acid polymerase for medical purposes; compositions for use in nucleic acid amplification for medical purposes; kits for use in nucleic acid amplification for medical purposes consisting of reagents, buffers, nucleic acid polymerase; chemical reagents for medical purposes; compositions for use in nucleic acid amplification for medical purposes; compositions for use in reverse transcription for medical purposes
Owner
- BIONEER CORPORATION, Daejeon, KR
- BIONEER CORPORATION, Daejeon, KR
- BIONEER CORPORATION, Daejeon, KR
Prosecution history
- 05 Jun 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
- 05 Jun 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED
- 26 May 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 14 Jan 2025 — TEAS SECTION 8 RECEIVED
- 24 Dec 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 24 Dec 2019 — REGISTERED-PRINCIPAL REGISTER
- 08 Oct 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Oct 2019 — PUBLISHED FOR OPPOSITION
- 18 Sept 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 03 Sept 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 30 Aug 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 30 Aug 2019 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 29 Aug 2019 — ASSIGNED TO LIE
- 23 Aug 2019 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 24 Apr 2019 — NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED